ERBB2 and breast cancer: A combinatorial nanocarrier system with a target size smaller than 200 nm suitable for passive cancer targeting utilizing enhanced permeability and retention was first constructed33.To endue active targeting specificity to HER2 overexpressed breast cancer cells, TZB was used to decorate carrier surface.